文献
J-GLOBAL ID:201702286089206369
整理番号:17A1233700
多発性硬化症における薬剤誘発性進行性多巣性白質脳症:ヨーロッパ調節因子の展望【Powered by NICT】
Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators’ perspective
著者 (9件):
Anton R
(European Medicines Agency, London, United Kingdom)
,
Haas M
(European Medicines Agency, London, United Kingdom)
,
Arlett P
(European Medicines Agency, London, United Kingdom)
,
Weise M
(Federal Institute for Drugs and Medical Devices, Bonn, Germany)
,
Balabanov P
(European Medicines Agency, London, United Kingdom)
,
Mazzaglia G
(European Medicines Agency, London, United Kingdom)
,
Prieto L
(European Medicines Agency, London, United Kingdom)
,
Keller-Stanislawski B
(Department of Safety of Medicinal Products and Medical Devices, Paul-Ehrlich Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany)
,
Raine J
(Medicines and Healthcare Products Regulatory Agency, London, United Kingdom)
資料名:
Clinical Pharmacology & Therapeutics
(Clinical Pharmacology & Therapeutics)
巻:
102
号:
2
ページ:
283-289
発行年:
2017年
JST資料番号:
A0721B
ISSN:
0009-9236
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)